Virtual companion 'Ida' may ease cancer distress in kids

NCT ID NCT07742059

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether an augmented reality (AR) app-based cognitive behavioral therapy (CBT) program can help children aged 6 to 12 who are undergoing chemotherapy for cancer cope with treatment-related distress and improve their quality of life. Participants are randomly assigned to one of three groups: one using the AR app 'My Hospital Buddy Ida,' another receiving the same CBT content through a printed workbook, and a control group receiving usual hospital care. The study compares changes in quality of life, resilience, anxiety, and treatment-related symptoms like nausea and fatigue across the groups over about 9 to 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Augmented reality-supported cognitive behavioral therapy (CBT) delivered via a smartphone/tablet app with an interactive companion character, compared to standard CBT via a printed workbook and usual care.
What this could lead to
If effective, this could offer a new, engaging way to help children with cancer manage treatment-related distress and improve their quality of life.
What could go wrong
The trial is relatively small and early, and the benefits of the AR app over standard CBT or usual care are not yet proven. The app may not be suitable for all children, and its effects could be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akdeniz Üniversitesi Hastanesi

    Antalya, Turkey (Türkiye)

  • Koç University Hospital

    Istanbul, Turkey (Türkiye)

  • Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi

    Istanbul, Turkey (Türkiye)

  • İstanbul Üniversitesi Onkoloji Enstitüsü

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.